Citadel Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$90.2M Sell
305,400
-3,100
-1% -$921K 0.01% 889
2025
Q4
$84.2M Buy
308,500
+1,000
+0.3% +$272K 0.01% 969
2025
Q3
$83.1M Sell
307,500
-61,200
-17% -$16.7M 0.01% 979
2025
Q2
$102M Buy
368,700
+42,500
+13% +$11.6M 0.02% 759
2025
Q1
$86.5M Buy
326,200
+127,000
+64% +$31.3M 0.02% 780
2024
Q4
$46.3M Sell
199,200
-55,400
-22% -$12.7M 0.01% 1340
2024
Q3
$56.2M Buy
254,600
+16,700
+7% +$3.46M 0.01% 1104
2024
Q2
$46.8M Sell
237,900
-19,600
-8% -$4.05M 0.01% 1202
2024
Q1
$55.4M Buy
257,500
+111,100
+76% +$23.3M 0.01% 1129
2023
Q4
$30.8M Sell
146,400
-55,500
-27% -$11.8M 0.01% 1595
2023
Q3
$40.4M Buy
201,900
+2,500
+1% +$497K 0.01% 1256
2023
Q2
$36.9M Sell
199,400
-12,400
-6% -$2.29M 0.01% 1299
2023
Q1
$40.6M Sell
211,800
-247,800
-54% -$44.8M 0.01% 1255
2022
Q4
$77.3M Buy
459,600
+101,200
+28% +$17.6M 0.02% 801
2022
Q3
$63.5M Buy
358,400
+43,300
+14% +$8.56M 0.01% 871
2022
Q2
$64.5M Sell
315,100
-8,100
-3% -$1.72M 0.02% 843
2022
Q1
$76.9M Buy
323,200
+88,900
+38% +$20.9M 0.02% 803
2021
Q4
$53.5M Sell
234,300
-83,600
-26% -$18.4M 0.01% 1117
2021
Q3
$61.5M Buy
317,900
+29,900
+10% +$6.06M 0.01% 969
2021
Q2
$61.3M Sell
288,000
-49,300
-15% -$10.4M 0.01% 970
2021
Q1
$68.9M Sell
337,300
-44,000
-12% -$8.67M 0.02% 794
2020
Q4
$69.4M Buy
381,300
+3,200
+0.8% +$544K 0.02% 751
2020
Q3
$63.3M Buy
378,100
+85,500
+29% +$14.4M 0.02% 708
2020
Q2
$47.6M Buy
292,600
+43,200
+17% +$7.74M 0.02% 833
2020
Q1
$43.1M Buy
249,400
+18,900
+8% +$3.76M 0.02% 715
2019
Q4
$46.3M Sell
230,500
-60,900
-21% -$12.5M 0.02% 816
2019
Q3
$61.6M Buy
291,400
+71,000
+32% +$14.8M 0.03% 637
2019
Q2
$42.8M Buy
220,400
+23,100
+12% +$4.26M 0.02% 836
2019
Q1
$32.5M Buy
197,300
+65,300
+49% +$11.5M 0.02% 959
2018
Q4
$24.8M Sell
132,000
-87,500
-40% -$16.2M 0.01% 1068
2018
Q3
$37.4M Buy
219,500
+5,500
+3% +$926K 0.02% 926
2018
Q2
$35.1M Buy
214,000
+97,000
+83% +$15.8M 0.02% 902
2018
Q1
$18.9M Sell
117,000
-45,000
-28% -$7.16M 0.01% 1165
2017
Q4
$23.7M Buy
162,000
+6,400
+4% +$911K 0.01% 1068
2017
Q3
$21.1M Buy
155,600
+27,000
+21% +$3.41M 0.02% 1033
2017
Q2
$16.1M Buy
128,600
+48,800
+61% +$5.84M 0.01% 1118
2017
Q1
$9.48M Sell
79,800
-49,100
-38% -$5.91M 0.01% 1486
2016
Q4
$14.9M Buy
128,900
+11,900
+10% +$1.32M 0.02% 1075
2016
Q3
$12.2M Buy
117,000
+7,100
+6% +$741K 0.01% 1197
2016
Q2
$10.7M Sell
109,900
-27,000
-20% -$2.55M 0.01% 1193
2016
Q1
$13.1M Sell
136,900
-147,000
-52% -$13.4M 0.02% 1009
2015
Q4
$25.7M Buy
283,900
+175,100
+161% +$16.5M 0.03% 704
2015
Q3
$10.1M Sell
108,800
-23,200
-18% -$2.21M 0.01% 1351
2015
Q2
$12.3M Sell
132,000
-12,000
-8% -$1.12M 0.01% 1332
2015
Q1
$13.6M Buy
144,000
+110,900
+335% +$10.3M 0.01% 1224
2014
Q4
$2.93M Sell
33,100
-130,500
-80% -$11.1M ﹤0.01% 2500
2014
Q3
$13.1M Buy
163,600
+31,600
+24% +$2.38M 0.01% 1190
2014
Q2
$9.37M Buy
132,000
+56,100
+74% +$3.95M 0.01% 1312
2014
Q1
$5.62M Sell
75,900
-51,200
-40% -$3.86M 0.01% 1678
2013
Q4
$9.97M Sell
127,100
-33,100
-21% -$2.59M 0.01% 1207
2013
Q3
$11.8M Buy
160,200
+21,100
+15% +$1.55M 0.02% 1007
2013
Q2
$10.6M Buy
+139,100
New +$9.13M 0.02% 1032

Other funds holding CME

Citadel Advisors's CME Position: Q1 2026 in Review

Citadel Advisors reduced its CME Group (CME) stake by 71% in Q1 2026, selling an estimated $274M and leaving 373,956 shares worth $110M. The position accounts for 0.02% of the portfolio, ranked #744.

Citadel Advisors first reported a position in CME in Q2 2013 and has held it in 52 quarters since. The position peaked at $354M in Q4 2025. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Citadel Advisors held 373,956 shares of CME Group worth $110M as of Q1 2026.
  • Citadel Advisors sold 923,691 CME Group shares in Q1 2026, an estimated $274M.
  • CME Group made up 0.02% of Citadel Advisors's portfolio in Q1 2026, its #744 holding.
  • Citadel Advisors first reported a position in CME Group in Q2 2013 and has held it in 52 quarters since.
  • Citadel Advisors's CME Group position peaked at $354M in Q4 2025.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.